Alexander Gintsburg Russia covid-19 Coronavirus Alexander Gintsburg Russia

Scientist behind Russia coronavirus vaccine defends ‘wartime’ rollout during trial

Reading now: 826
globalnews.ca

Russia plans to share preliminary results of its COVID-19 vaccine trial based on the first six weeks of monitoring participants, raising the tempo in an already frenzied global race to end the pandemic.Alexander Gintsburg, head of the Gamaleya Institute that produced the Sputnik V vaccine, told Reuters that the pace of its development was necessary under the “wartime” conditions of a pandemic but no corners were being cut.

Russia ‘so confident’ in coronavirus vaccine it will shoulder legal liability Russia has pushed ahead with its potential COVID-19 vaccine at top speed with mass public vaccinations alongside the main human trial, raising concerns among some observers that it was prioritizing national prestige over solid science and.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA